177 related articles for article (PubMed ID: 36527747)
1. UCHL3 promotes cervical cancer development and metastasis by stabilizing NRF2 via deubiquitination.
Zhang Y; Liu JB; Liu J; Liu M; Liu HL; Zhang J
Biochem Biophys Res Commun; 2023 Jan; 641():132-138. PubMed ID: 36527747
[TBL] [Abstract][Full Text] [Related]
2. Functional Role of NRF2 in Cervical Carcinogenesis.
Ma JQ; Tuersun H; Jiao SJ; Zheng JH; Xiao JB; Hasim A
PLoS One; 2015; 10(8):e0133876. PubMed ID: 26247201
[TBL] [Abstract][Full Text] [Related]
3. LINC00665 knockdown confers sensitivity in irradiated non-small cell lung cancer cells through the miR-582-5p/UCHL3/AhR axis.
Xu LM; Yuan YJ; Yu H; Wang S; Wang P
J Transl Med; 2022 Aug; 20(1):350. PubMed ID: 35918714
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway.
Tang J; Yang Q; Mao C; Xiao D; Liu S; Xiao L; Zhou L; Wu G; Tao Y
Cell Death Differ; 2023 May; 30(5):1247-1259. PubMed ID: 36813921
[TBL] [Abstract][Full Text] [Related]
5. UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway.
Zhang MH; Zhang HH; Du XH; Gao J; Li C; Shi HR; Li SZ
Oncogene; 2020 Jan; 39(2):322-333. PubMed ID: 31477831
[TBL] [Abstract][Full Text] [Related]
6. UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.
Song Z; Li J; Zhang L; Deng J; Fang Z; Xiang X; Xiong J
Am J Cancer Res; 2019; 9(9):1970-1981. PubMed ID: 31598398
[TBL] [Abstract][Full Text] [Related]
7. The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor.
Ouyang L; Yan B; Liu Y; Mao C; Wang M; Liu N; Wang Z; Liu S; Shi Y; Chen L; Wang X; Cheng Y; Cao Y; Xiao D; Zhang L; Liu S; Tao Y
Signal Transduct Target Ther; 2020 Jun; 5(1):78. PubMed ID: 32546741
[TBL] [Abstract][Full Text] [Related]
8. Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression.
Liu T; Fan MQ; Xie XX; Shu QP; Du XH; Qi LZ; Zhang XD; Zhang MH; Shan G; Du RL; Li SZ
J Transl Med; 2023 Sep; 21(1):656. PubMed ID: 37740194
[TBL] [Abstract][Full Text] [Related]
9. UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin.
Ma Q; Lu Q; Lei X; Zhao J; Sun W; Wang J; Zhu Q; Huang D
Front Oncol; 2023; 13():1088475. PubMed ID: 36969045
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
11. Circ
Xie G; Lei B; Yin Z; Xu F; Liu X
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474064
[TBL] [Abstract][Full Text] [Related]
12. GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH.
Yang R; Liu N; Chen L; Jiang Y; Shi Y; Mao C; Liu Y; Wang M; Lai W; Tang H; Gao M; Xiao D; Wang X; Zhou H; Tang CE; Liu W; Yu F; Cao Y; Yan Q; Liu S; Tao Y
Oncogene; 2019 Nov; 38(46):7133-7145. PubMed ID: 31417184
[TBL] [Abstract][Full Text] [Related]
13. GSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer.
Shan W; Peng W; Chen Y; Wang Y; Yu Q; Tian Y; Dou Y; Tu J; Huang X; Li X; Wang Z; Zhu Q; Chen J; Xia B
Oncogene; 2024 Apr; ():. PubMed ID: 38664501
[TBL] [Abstract][Full Text] [Related]
14. UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression.
Fan Y; Hu D; Li D; Ma C; Tang Y; Tao Q; Deng L; Tang D
Clin Transl Oncol; 2021 Aug; 23(8):1637-1645. PubMed ID: 33616859
[TBL] [Abstract][Full Text] [Related]
15. K27-Linked Diubiquitin Inhibits UCHL3 via an Unusual Kinetic Trap.
van Tilburg GBA; Murachelli AG; Fish A; van der Heden van Noort GJ; Ovaa H; Sixma TK
Cell Chem Biol; 2021 Feb; 28(2):191-201.e8. PubMed ID: 33238157
[TBL] [Abstract][Full Text] [Related]
16. USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.
Diao W; Guo Q; Zhu C; Song Y; Feng H; Cao Y; Du M; Chen H
BMC Cancer; 2020 Aug; 20(1):741. PubMed ID: 32770981
[TBL] [Abstract][Full Text] [Related]
17. UCHL3 promotes proliferation of colorectal cancer cells by regulating SOX12 via AKT/mTOR signaling pathway.
Li J; Zheng Y; Li X; Dong X; Chen W; Guan Z; Zhang C
Am J Transl Res; 2020; 12(10):6445-6454. PubMed ID: 33194042
[TBL] [Abstract][Full Text] [Related]
18. UCHL-3 as a potential biomarker of ovarian cancer.
Yang Q; Peng X; Nian Z; Yuan S; Wang Z; Song Y; Shamsnur R; Wang H; Yi T
Gynecol Oncol; 2024 Mar; 182():156-167. PubMed ID: 38266402
[TBL] [Abstract][Full Text] [Related]
19. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
Su J; Zhang F; Li X; Liu Z
Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
[TBL] [Abstract][Full Text] [Related]
20. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
